Object of these supplies: delivering, placing, at the service and maintenance of two PET Infusion System for creating patient doses of radiopharmaceutical agents
Navidea Biopharmaceuticals is a commercial stage precision medicine company focused on the development and commercialization of precision diagnostics, therapeutics and radiopharmaceutical agents
In addition, Neoprobe holds significant interests in the development of related biomedical systems and radiopharmaceutical agents
including Lymphoseek[R] and RIGScanTM CR.
As new PET radiopharmaceutical agents
for use in the evaluation of Alzheimer's and other cognitive diseases gain approval by the Food and Drug Administration (FDA), Siemens Healthcare's early efforts have allowed the company to promptly design and deliver the industry's first end-to-end amyloid PET imaging solution.